Back to UBS Group AG UBS Group AG

ARWRARWR
30 quarters

Position history for UBS Group AGUBS Group AG's holdings in ARROWHEAD PHARMACEUTICALS IN

UBS Group AG holds 861,520 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $70.2M as of 2026-Q2. The position was decreased (-35.5% shares). ARWR represents 0.0% of UBS Group AG's portfolio.

Current Value

$70.2M

Current Shares

861,520

Total Value Change

+$69.2M

Total Shares Change

+806,906

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
861,520
-35.5%
$70.2M0.0%$81.51
0
2026-Q1
Increased
1.3M
+35.4%
$83.8M0.0%$64.10
39
2025-Q4
Increased
987,287
+7.5%
$65.5M0.0%$67.25
32
2025-Q3
Decreased
918,183
-42.6%
$31.7M0.0%$33.78
0
2025-Q2
Decreased
1.6M
-1.6%
$25.3M0.0%$16.08
0
2025-Q1
Increased
1.6M
+24.6%
$20.7M0.0%$13.82
35
2024-Q4
Increased
1.3M
+195.7%
$24.5M0.0%$18.61
46
2024-Q3
Increased
441,511
+26.8%
$8.6M0.0%$19.67
34
2024-Q2
Decreased
348,304
-22.8%
$9.1M0.0%$25.99
0
2024-Q1
Decreased
450,921
-11.3%
$12.9M0.0%$28.60
0
2023-Q4
Increased
508,586
+37.6%
$15.6M0.0%$30.60
37
2023-Q3
Increased
369,602
+11.7%
$9.9M0.0%$26.87
31
2023-Q2
Increased
330,970
+10.6%
$11.8M0.0%$35.93
31
2023-Q1
Decreased
299,342
-2.7%
$7.6M0.0%$24.43
0
2022-Q4
Increased
307,710
+197.2%
$12.5M0.0%$40.56
45
2022-Q3
Increased
103,546
+13.5%
$3.4M0.0%$33.28
30
2022-Q2
Decreased
91,217
-42.8%
$3.2M0.0%$34.56
0
2022-Q1
Increased
159,326
+2.8%
$7.3M0.0%$45.59
28
2021-Q4
Increased
155,016
+19.2%
$10.3M0.0%$67.35
33
2021-Q3
Increased
130,000
+80.0%
$8.1M0.0%$60.63
42
2021-Q2
Increased
72,213
+0.4%
$6M0.0%$81.50
27
2021-Q1
Increased
71,941
+522.6%
$4.8M0.0%$63.69
43
2020-Q4
Decreased
11,555
-65.1%
$887,0000.0%$77.43
0
2020-Q3
Increased
33,138
+324.6%
$1.4M0.0%$43.42
41
2020-Q2
Decreased
7,804
-35.3%
$337,0000.0%$42.60
0
2020-Q1
Decreased
12,053
-94.2%
$347,0000.0%$28.97
0
2019-Q4
Decreased
208,175
-1.5%
$13.2M0.0%$64.20
0
2019-Q3
Increased
211,411
+84.8%
$6M0.0%$26.96
42
2019-Q2
Increased
114,426
+109.5%
$3M0.0%$26.50
43
2019-Q1
New
54,614
-
$1M0.0%$18.35
35

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used